CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- 4 Open-market buy Chief Commercial Officer bought 33,300 shares at $0.36 ($11,988)
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Chief Commercial Officer bought 40,000 shares at $0.45 ($18,000)
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Chief Commercial Officer bought 40,000 shares at $0.35 ($14,000)
- 4 Open-market buy Chief Financial Officer bought 27,500 shares at $0.38 ($10,450)
- 4 Open-market buy Chief Commercial Officer bought 38,700 shares at $0.38 ($14,706)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $0.40 ($10,000)
- 4 Open-market buy Chief Commercial Officer bought 48,000 shares at $0.39 ($18,720)
- 4 Open-market buy Chief Financial Officer bought 52,000 shares at $0.39 ($20,280)
- 8-K Event Other events
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
Page 18 of 59 · 1,164 filings